IE812722L - Naphthyridine derivatives - Google Patents

Naphthyridine derivatives

Info

Publication number
IE812722L
IE812722L IE812722A IE272281A IE812722L IE 812722 L IE812722 L IE 812722L IE 812722 A IE812722 A IE 812722A IE 272281 A IE272281 A IE 272281A IE 812722 L IE812722 L IE 812722L
Authority
IE
Ireland
Prior art keywords
naphthyridine
derivatives
indolo
hexahydro
hydrogen atom
Prior art date
Application number
IE812722A
Other versions
IE52160B1 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IE812722L publication Critical patent/IE812722L/en
Publication of IE52160B1 publication Critical patent/IE52160B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Secondary Cells (AREA)
  • Electrolytic Production Of Metals (AREA)
  • Carbon And Carbon Compounds (AREA)
  • X-Ray Techniques (AREA)

Abstract

2,3,3a,4,5,6-Hexahydro-1H-indolo[3,2,1-de][1,5-naphthyridine] derivatives of the general formula: <IMAGE> in which R1 is in the 9- or 10- position and represents a hydrogen atom, a halogen atom or a C1-4 alkyl or C1-4 alkoxy radical and R2 represents a hydrogen atom or a C1-4 alkyl radical, and pharmaceutically acceptable acid addition salts thereof are new compounds useful in therapy as they possess an anti- anoxia action and a psychotropic action. They can be prepared by reduction of the carbonyl group of corresponding 1,2,3,3a,4,5-hexahydro- 6H-indolo[3,2,1-de][1,5-naphthyridine]-6-one derivatives, which are known compounds, to methylene. [GB2087889A]
IE2722/81A 1980-11-21 1981-11-20 Naphthyridine derivatives IE52160B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8024717A FR2494693A1 (en) 1980-11-21 1980-11-21 DERIVATIVES OF HEXAHYDRO-2,3,3A, 4,5,6 1H-INDOLO (3,2,1-DE) (NAPHTHYRIDINE-1,5), THEIR PREPARATION AND THEIR THERAPEUTIC USE

Publications (2)

Publication Number Publication Date
IE812722L true IE812722L (en) 1982-05-21
IE52160B1 IE52160B1 (en) 1987-07-22

Family

ID=9248208

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2722/81A IE52160B1 (en) 1980-11-21 1981-11-20 Naphthyridine derivatives

Country Status (22)

Country Link
JP (1) JPS57116070A (en)
AT (1) AT379594B (en)
AU (1) AU546924B2 (en)
BE (1) BE891204A (en)
CA (1) CA1162544A (en)
CH (1) CH649549A5 (en)
DE (1) DE3143179A1 (en)
DK (1) DK515681A (en)
ES (1) ES8207176A1 (en)
FR (1) FR2494693A1 (en)
GB (1) GB2087889B (en)
GR (1) GR78026B (en)
IE (1) IE52160B1 (en)
IL (1) IL64328A (en)
IT (1) IT1195292B (en)
LU (1) LU83775A1 (en)
NL (1) NL8105282A (en)
NO (1) NO813945L (en)
NZ (1) NZ199008A (en)
PT (1) PT74019B (en)
SE (1) SE8106918L (en)
ZA (1) ZA818082B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527210A1 (en) * 1982-05-18 1983-11-25 Synthelabo ENANTIOMERS OF HEXAHYDRO-2,3,3A, 4,5,6 1H-INDOLO (3,2,1-DE) (NAPHTHYRIDINE-1,5), THEIR SEPARATION METHOD AND THEIR THERAPEUTIC APPLICATION
EP0357417A1 (en) * 1988-09-01 1990-03-07 Glaxo Group Limited Lactam derivatives
CN113214250B (en) * 2021-04-28 2022-06-14 华南理工大学 Synthetic method of fused hexahydro-1, 6-naphthyridine compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD129791A5 (en) * 1976-04-13 1978-02-08 Synthelabo PROCESS FOR THE PREPARATION OF NAPHTYRIDINE DERIVATIVES
GB1550496A (en) * 1976-12-31 1979-08-15 Logeais Labor Jacques 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications

Also Published As

Publication number Publication date
AU546924B2 (en) 1985-09-26
ES507317A0 (en) 1982-09-01
FR2494693B1 (en) 1983-03-04
PT74019A (en) 1981-12-01
IE52160B1 (en) 1987-07-22
NZ199008A (en) 1984-07-31
AT379594B (en) 1986-01-27
CH649549A5 (en) 1985-05-31
DK515681A (en) 1982-05-22
IT1195292B (en) 1988-10-12
ZA818082B (en) 1982-10-27
FR2494693A1 (en) 1982-05-28
LU83775A1 (en) 1983-09-01
GB2087889B (en) 1984-01-25
SE8106918L (en) 1982-05-22
AU7770081A (en) 1982-05-27
NL8105282A (en) 1982-06-16
GR78026B (en) 1984-09-26
BE891204A (en) 1982-05-21
DE3143179A1 (en) 1982-06-24
ES8207176A1 (en) 1982-09-01
IL64328A (en) 1985-02-28
CA1162544A (en) 1984-02-21
NO813945L (en) 1982-05-24
IT8125212A0 (en) 1981-11-20
GB2087889A (en) 1982-06-03
IL64328A0 (en) 1982-02-28
JPS57116070A (en) 1982-07-19
ATA501381A (en) 1985-06-15
PT74019B (en) 1983-12-07

Similar Documents

Publication Publication Date Title
NO943093L (en) Process for the preparation of clavulanic acid
GR3018387T3 (en) Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.
IE45439L (en) Penicillanic acid derivatives
ES8707541A1 (en) Cephalosporin derivatives.
DE3177159D1 (en) 2-OXIMINO-2-AMINOTHIAZOLYL ACETIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
IE780119L (en) IMIDAZO(1,2-a) QUINOLINE-2-CARBOXYLIC ACIDS
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
IE44339L (en) Piperazine derivatives.
IE781013L (en) Pyrido-indole tranquilisers
IE801220L (en) Pyridopyrimidines
IE812722L (en) Naphthyridine derivatives
NZ225659A (en) Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
IE45178L (en) Phenothiazine derivatives
IE42672L (en) Thieno-tetrahydropyridine derivatives
DE3269247D1 (en) Derivatives of 2-phenyl-morpholine and medical compositions
AU530930B2 (en) Pharmaceutical compositions and method of treating heart disease
IE831075L (en) Thiophene derivatives
JPS56118081A (en) Preparation of 6-methoxy-1,8-naphthyridine
IE810080L (en) Triazolobenzopyrans
IE42992L (en) PYRIMIDO [1,2-a] QUINOLINE DERIVATIVES
IE821204L (en) Quinidine derivatives.
AU2742288A (en) Novel compound effective as cerebral insufficiency improver
IE780742L (en) Isoxazolylmethyl-benzomorphanes
JPS5430198A (en) Pyrido(2,3-b) phenothiazines